MedTrace Logo

Efficacy of Tomosynthesis in the BIRADS 3 Population

NCT00763100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 690

Last updated 2011-01-06

No results posted yet for this study

Summary

There are three main objectives, centering on those patients targeted for surveillance imaging. The first objective is to compare image quality and specificity of breast tomosynthesis and conventional 2D mammography in a BIRADS 3 diagnostic population. The second objective is to compare image quality and ability to determine post-surgical and post-radiation changes from recurrence in a post-cancer subset of a BIRADS 3 population having undergone conservation therapy (lumpectomy with or without radiation. The final objective is to compare image quality and the ability to determine chemoresponsiveness in a post-cancer subset of a BIRADS 3 population, who are undergoing neoadjuvant chemotherapy.

Conditions

Sponsors & Collaborators

  • Hologic, Inc.

    collaborator INDUSTRY

  • WellSpan Health

    lead OTHER

Principal Investigators

  • Joanne Trapeni, DO · WellSpan Health

Eligibility

Min Age
26 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-11-30
Completion
2009-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00763100 on ClinicalTrials.gov